★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN   Learn more →

Log In  |  Become a Member  |  Sponsor  |  ⌕ Search

Established in 1999

News/Compliance & Enforcement/Compound Ingredient Supplier to Pay Over $22 Million to Resolve Allegations Brought Under Qui Tam Provisions of FCA
Expert Opinion·Compliance & Enforcement Brief

Compound Ingredient Supplier to Pay Over $22 Million to Resolve Allegations Brought Under Qui Tam Provisions of FCA

PA
PubK AdminNovember 27, 2019 · 1 min read
🔒 Members Only

Fagron Holding USA LLC has agreed to pay $22.05 million to resolve allegations regarding false and inflated Average Wholesale Prices established by its subsidiary, Freedom Pharmaceuticals Inc., a supplier of compound ingredients utilized in prescriptions.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year
Become a Member
Sign In
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.